LOGO_HEADLOGO_HEADLOGO_HEADLOGO_HEAD
  • HOME
  • ABOUT US
  • TEAM
  • SERVICES
    • MEDICAL WRITING
    • BIOSTATISTICS
    • EC & CA SUBMISSIONS
    • CLINICAL OPERATIONS
    • CEVAC CLINICS – VACCINOLOGY CENTER
    • CEVAC IMMUNOLOGY LABORATORY
    • e-CRF AND e-PLATFORM
    • DATA MANAGEMENT
    • SAFETY & PHARMACOVIGILANCE
    • REGULATORY AFFAIRS
    • INTEGRATED CLINICAL REPORT
    • PUBLICATIONS
  • PUBLICATIONS
  • CASE STUDIES
  • LINKS
  • CONTACT

A phase 1/2 clinical trial evaluating safety and immunogenicity

A phase 1/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults.

Leroux-Roels I, Leroux-Roels G, Clement F, Vandepapelière P, Vassilev V, Ledent E, Heineman TC. J Infect Dis.

2012 Oct;206(8):1280-9

Read the article

Vaxxium is a consortium that brings together highly qualified industry, academic and education experts for vaccine development.

Rue de la Stationstraat 78

1630 Linkebeek

Tel : +32 2 383 04 55

Fax : +32 2 383 04 56

info@vaxxium.com

LASTEST NEWS

  • Adjuvant-Associated Peripheral Blood mRNA Profiles

QUICK LINKS

HOME
SMART LINKS
SERVICES
PUBLICATIONS
CONTACT
COPYRIGHT ©2018 VAXXIUM. TOUS DROITS RESERVES